• Explore /
  • Poster
  • / Anlotinib plus chemotherapy as first-line therapy for patients with gastrointestinal tumor with unresectable liver metastasis: Updated results from multi-cohort, multi-center phase II trial ALTER-G-001-cohort A.

Anlotinib plus chemotherapy as first-line therapy for patients with gastrointestinal tumor with unresectable liver metastasis: Updated results from multi-cohort, multi-center phase II trial ALTER-G-001-cohort A.

Abstract Poster

Authors

null

Junwei Wu

Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Junwei Wu , Lingjun Zhu , Chenfei Zhou , Min Shi , Jun Chen , Liqin Zhao , Zhengxiang Han , Chunbing Wang , Jinling Jiang , Jun Yan , Chun Wang , Xiaowei Wei , Yong Mao , Donghai Cui , Xiuli Yang , Zhiquan Qin , Xinyu Tang , Jun Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05262335

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 112)

DOI

10.1200/JCO.2024.42.3_suppl.112

Abstract #

112

Poster Bd #

G16

Abstract Disclosures

Similar Posters

First Author: Junwei Wu

First Author: Jing Liu

First Author: Hendrik-Tobias Arkenau

First Author: Gong-Rang Chen